Home > Research > Publications & Outputs > Vibration spectroscopy of biofluids for disease...


Text available via DOI:

View graph of relations

Vibration spectroscopy of biofluids for disease screaning or diagnosis: translation from the laboratory to a clinical setting

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>04/2014
<mark>Journal</mark>Journal of Biophotonics
Issue number3-4
Number of pages13
Pages (from-to)153-165
Publication StatusPublished
Early online date19/03/14
<mark>Original language</mark>English


There remains a need for objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings. Given an increasingly ageing population resulting in a rising prevalence of chronic diseases, the need for screening to facilitate the personalising of therapies to prevent or slow down pathology development will increase. Such a tool needs to be robust but simple enough to be implemented into clinical practice. There is interest in extracting biomarkers from biofluids (e.g., plasma or serum); techniques based on vibrational spectroscopy provide an option. Sample preparation is minimal, techniques involved are relatively low-cost, and data frameworks are available. This review explores the evidence supporting the applicability of vibrational spectroscopy to generate spectral biomarkers of disease in biofluids. We extend the inter-disciplinary nature of this approach to hypothesise a microfluidic platform that could allow such measurements. With an appropriate lightsource, such engineering could revolutionize screening in the 21st century.